Abstract Details
Activity Number:
|
547
|
Type:
|
Contributed
|
Date/Time:
|
Wednesday, August 7, 2013 : 10:30 AM to 12:20 PM
|
Sponsor:
|
Biopharmaceutical Section
|
Abstract - #309853 |
Title:
|
Assessing the Cumulative Exposure Response in Alzheimer's Disease Studies
|
Author(s):
|
Jianing Di*+ and Xin Zhao and Daniel Wang and Ming Lu and Michael Krams
|
Companies:
|
Janssen R&D, LLC and Janssen R&D, LLC and Janssen R&D, LLC and Janssen R&D, LLC and Janssen R&D, LLC
|
Keywords:
|
Cumulative exposure response ;
disease progression model ;
Alzheimer's disease ;
MMRM ;
dropout effect
|
Abstract:
|
To assess long-term cumulative benefit of a treatment, the relationship between cumulative drug exposure and outcomes could be explored to understand dose response. However, cumulative exposure corresponds to the longitudinal profile of an outcome, which is heavily confounded with natural disease progression and missing data. A model-based approach is developed to account for the confounding factors. In particular, the observed measures are adjusted by the projected disease progression at the corresponding time points before exposure response is assessed. The proposed approach introduces new insights to the interpretation of study data. In the case study used to demonstrate the method, there seem to be various degrees of efficacy trend favoring higher level of cumulative exposure in active drug, based on selected clinical and biomarker endpoints.
|
Authors who are presenting talks have a * after their name.
Back to the full JSM 2013 program
|
2013 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Copyright © American Statistical Association.